Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

targeting calpain-2 for people living with amyotrophic lateral sclerosis (ALS). With the clinical hold lifted, Amylyx is now working to open U.S. sites for screening, enrollment, and dosing.

a Professor of Medicine and Multiple Sclerosis Clinical Research Chair at Dalhousie University. While people with MS consistently showed elevated risk, the findings suggest a broader need for ...

Explore the role of preclinical MRI in studying neurological diseases, with a focus on advanced cellular and molecular ...

Aim The present study evaluated whether the MRI parameters of hamstring injuries in male professional football players correlate with time to return to play (RTP). Methods 46 elite European football ...

Incidental findings in brain magnetic resonance imaging (MRI) refer to unexpected abnormalities discovered during scans that were performed for other reasons. As the use of MRI has become more ...

neura.edu.au Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder of the motor neurons in the motor cortex, brainstem and spinal cord. A combination of upper and ...

Toronto, ON, January 22, 2025 – People with multiple sclerosis (MS ... with a mental illness in the first year postpartum. "Our findings highlight the heightened vulnerability of mothers ...

The new findings show the cancer mortality rate declined by ... Study Finds Surprising Way That Genetic Mutation Causes Huntington's Disease, Transforming Understanding of the Disorder Jan. 16 ...

July 15, 2024 — Early exposure to antibiotics can trigger long term susceptibility to asthma, according to new research. Importantly the research team isolated a ... Jan. 15, 2025 ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...